Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily K Zboril

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Cell Science|November 15, 2019
Loss of Ca<sup>2+</sup> entry via Orai-TRPC1 induces ER stress, initiating immune activation in macrophagesViviane Nascimento Da Conceicao, Yuyang Sun, Emily K Zboril, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 3, 2026
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancerJulia E Altman, Aaron Valentine, Nina Dashti-Gibson, et al.
Frontiers in Physiology|October 3, 2022
Inhibition of Ca<sup>2+</sup> entry by capsazepine analog CIDD-99 prevents oral squamous carcinoma cell proliferationYuyang Sun, Emily K Zboril, Jorge J De La Chapa, et al.
Cancers|June 28, 2023
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast CancerEmily K Zboril, Jacqueline M Grible, David C Boyd, et al.
Cancers|March 11, 2023
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXsDavid C Boyd, Emily K Zboril, Amy L Olex, et al.
Scientific Reports|December 9, 2022
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancerNarmeen S Rashid, David C Boyd, Amy L Olex, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Cell Science|November 15, 2019
Loss of Ca<sup>2+</sup> entry via Orai-TRPC1 induces ER stress, initiating immune activation in macrophagesViviane Nascimento Da Conceicao, Yuyang Sun, Emily K Zboril, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 3, 2026
Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancerJulia E Altman, Aaron Valentine, Nina Dashti-Gibson, et al.
Frontiers in Physiology|October 3, 2022
Inhibition of Ca<sup>2+</sup> entry by capsazepine analog CIDD-99 prevents oral squamous carcinoma cell proliferationYuyang Sun, Emily K Zboril, Jorge J De La Chapa, et al.
Cancers|June 28, 2023
Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast CancerEmily K Zboril, Jacqueline M Grible, David C Boyd, et al.
Cancers|March 11, 2023
Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXsDavid C Boyd, Emily K Zboril, Amy L Olex, et al.
Scientific Reports|December 9, 2022
Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancerNarmeen S Rashid, David C Boyd, Amy L Olex, et al.
Clinical and Translational Medicine|October 17, 2024
Single-cell transcriptional atlas of human breast cancers and model systemsJulia E Altman, Amy L Olex, Emily K Zboril, et al.
Pageof 1